- CORRESPONDENCE
Equitable drug access: small-scale manufacturing units can help
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 609, 245 (2022)
doi: https://doi.org/10.1038/d41586-022-02803-8
Competing Interests
K.R.L. is an owner, shareholder and employee of Sunflower Therapeutics PBC. Ameer Basrai is an employee and shareholder of Roivant Sciences. Anthony Bogachev is an employee of Roivant Social Ventures and a shareholder of Rovant Sciences. F.R. is a consultant for the Bill & Melinda Gates Foundation and a member of the board of directors of VaxThera, a Sura Company.